Rule 17.8.770 - ADDITIONAL REQUIREMENTS FOR INCINERATORS(1) An applicant for a Montana air quality permit for an incineration facility subject to 75-2-215, MCA, shall submit a human health risk assessment protocol and a human health risk assessment as part of the application. The human health risk assessment must demonstrate that the ambient concentrations of pollutants resulting from emissions from the incineration facility subject to 75-2-215, MCA, constitute no more than a negligible risk to the public health, safety, and welfare and to the environment. At a minimum, the human health risk assessment must meet the following requirements: (a) The human health risk assessment must include an emissions inventory listing potential emissions of all pollutants specified in the Federal Clean Air Act Hazardous Air Pollutants List (as defined in section 112(b) of the FCAA);(b) A characterization of emissions and ambient concentrations of air pollutants, including hazardous air pollutants, from any existing emitting unit at the facility must be submitted as part of the permit application;(c) The human health risk assessment must address the impacts of all pollutants inventoried in (1) (a), except as provided in (1) (c) (i) and (ii). Pollutants may be excluded from the human health risk assessment if the department determines that exposure from inhalation is the only appropriate pathway to consider in the human health risk assessment and if: (i) the potential to emit the pollutant is less than 1.28 x 10-13 grams per second, if the incineration facility subject to 75-2-215, MCA, has a stack height of at least two meters, a stack velocity of at least 0.645 meters per second, and a stack exit temperature of at least 800° F, and there is a distance of at least five meters from the stack to the property boundary; or(ii) the ambient concentrations of the pollutants (calculated using the potential to emit; enforceable limits or controls may be considered) are less than the levels specified in Table 1 or Table 2.(iii) The department shall periodically review accepted toxicity value databases to determine if the de minimis levels in (1) (c) (i) and (ii) should be updated;(d) The human health risk assessment must address risks from all appropriate exposure pathways. For incineration facilities subject to 75-2-215, MCA, that do not emit or emit only minute amounts of hazardous air pollutants contained in Tables 4-1 or 4-2 of the department's health risk assessment procedures/model the application need address only impact from the inhalation exposure pathway and may use a department supplied screening model to assess human health risk;(e) The human health risk assessment must address the human health risk impact of all hazardous air pollutants, as described in (1) (a), from the emitting unit or units that constitutes the incineration facility subject to 75-2-215, MCA, from all other existing incineration facilities subject to 75-2-215, MCA, at the facility, and from all other new or existing emitting units solely supporting any incineration facility subject to 75-2-215, MCA, such as fugitive emissions from fuel storage; (i) Emissions from existing emitting units that partially support the incineration facility, but that do not change the type or amount of emissions allowed under any existing permit in effect at the time of the permit application, need not be considered in the human health risk assessment;(ii) If an existing emitting unit, wholly or partially supporting the incineration facility, increases the types or amount of its emissions, so that a permit modification is required, that portion of the emissions increase attributable to the support of the incineration facility must be considered in the human health risk assessment;(f) The health risk assessment must be performed in accordance with accepted human health risk assessment practices, or state or federal guidelines in effect at the time the human health risk assessment is performed, and must address impacts on sensitive populations. The human health risk must be calculated using the emitting unit's potential to emit. Enforceable limits or controls may be considered. The human health risk assessment procedures used may be modified if site-specific conditions warrant use of alternative procedures to appropriately assess human health risk;(g) As part of the application, the applicant shall submit to the department a human health risk assessment protocol detailing the human health risk assessment procedures. At a minimum, the human health risk assessment protocol must include: (i) a description of the pollutants considered in the analysis;(ii) methods used in compiling the emission inventory;(iii) ambient dispersion models and modeling procedures used;(iv) toxicity values for each pollutant;(v) exposure pathways and assumptions;(vi) any statistical analysis applied; and(vii) any other information necessary for the department to review the adequacy of the human health risk assessment;(h) A summary of the human health risk assessment protocol must be included in the permit analysis. The summary must: (i) clearly define the scope of the risk assessment;(ii) describe the exposure pathways used;(iii) specify any pollutants identified in the emission inventory that were not required to be included in the human health risk assessment;(iv) state whether, and to what extent, the impacts of existing emissions, or the synergistic effect of combined pollutants, were considered in the final human health risk level calculated to determine compliance with the negligible risk standard; and(v) state that environmental effects unrelated to human health were not considered in determining compliance with the negligible risk standard, but were evaluated as required by the Montana Environmental Policy Act, in determining compliance with all applicable rules or other requirements requiring protection of public health, safety, and welfare and the environment;(i) The department may impose additional requirements for the human health risk assessment, on a case-by-case basis, if the department reasonably believes that the type or amount of material being incinerated, the proximity to sensitive populations, short-term emissions variations, acute health impact, or the local topographical or ventilation conditions require a more detailed health risk assessment to adequately define the potential public health impact. Additional requirements for the human health risk assessment may include specific emission inventory procedures for determining emissions from the incineration facility subject to 75-2-215, MCA, use of more sophisticated air dispersion models or modeling procedures and consideration of additional exposure pathways. TABLE 1
| CAS # | CHEMICAL | CANCER ANNUAL (µg/m3) |
| 75070 | Acetaldehyde | 4.5455e-02 |
| 79061 | Acrylamide | 7.6923e-05 |
| 107131 | Acrylonitrile | 1.4706e-03 |
| 1332214 | Asbestos | 5.1546e-04 |
| 71432 | Benzene | 1.2048e-02 |
| 92875 | Benzidine | 1.4925e-06 |
| 117817 | Bis(2-Ethylhexyl) Phthalate (DEHP) | 4.1667e-02 |
| 542881 | Bis(Chloromethyl) Ether | 1.6129e-06 |
| 75252 | Bromoform | 9.0909e-02 |
| 106990 | 1,3-Butadiene | 3.5714e-04 |
| 56235 | Carbon Tetrachloride | 6.6667e-03 |
| 57749 | Chlordane | 2.7027e-04 |
| 67663 | Chloroform | 4.3478e-03 |
| 126998 | Chloroprene | 7.6923e-01 |
| 132649 | Dibenzofurans | 2.6316e-09 |
| 96128 | 1,2-Dibromo-3-Chloropropane | 5.0000e-05 |
| 106467 | 1,4-Dichlorobenzene (p) | 9.0909e-03 |
| 91941 | 3,3-Dichlorobenzidene | 2.9412e-04 |
| 111444 | Dichloroethyl Ether | 3.0303e-04 |
| 123911 | 1,4-Dioxane (1,4-Diethyleneoxide) | 1.2987e-02 |
| 122667 | 1,2-Diphenylhydrazine | 4.5455e-04 |
| 106898 | Epichlorohydrin | 8.3333e-02 |
| 51796 | Ethyl Carbamate (Urethane) | 3.4483e-04 |
| 106934 | Ethylene Dibromide | 4.5455e-04 |
| 107062 | Ethylene Dichloride | 3.8462e-03 |
| 75218 | Ethylene Oxide | 1.1364e-03 |
| 50000 | Formaldehyde | 7.6923e-03 |
| 76448 | Heptachlor | 7.6923e-05 |
| 118741 | Hexachlorobenzene | 2.1739e-04 |
| 87683 | Hexachlorobutadiene | 4.5455e-03 |
| 67721 | Hexachloroethane | 2.5000e-02 |
| 302012 | Hydrazine | 2.0408e-05 |
| 58899 | Lindane (All Isomers) | 9.0909e-05 |
| 75092 | Methylene Chloride | 2.1277e-01 |
| 62759 | N-Nitrosodimethylamine | 7.1429e-06 |
| 87865 | Pentachlorophenol | 2.1739e-02 |
| 1336363 | Polychlorinated Biphenyls | 7.1429e-05 |
| 75569 | Propylene Oxide | 2.7027e-02 |
| 1746016 | 2,3,7,8-TCDD | 2.6316e-09 |
| 79345 | 1,1,2,2-Tetrachloroethane | 1.7241e-03 |
| 127184 | Tetrachloroethylene (Perch) | 1.6949e-02 |
| 8001352 | Toxaphene | 3.1250e-04 |
| 79005 | 1,1,2-Trichloroethane | 6.2500e-03 |
| 79016 | Trichloroethylene | 5.0000e-02 |
| 88062 | 2,4,6-Trichlorophenol | 3.2258e-02 |
| 75014 | Vinyl Chloride | 1.2821e-03 |
| 75354 | Vinylidene Chloride | 2.0000e-03 |
| Arsenic Compounds | 2.3256e-05 |
| Beryllium Compounds | 4.1667e-05 |
| Cadmium Compounds | 5.5556e-05 |
| Chromium Compounds | 8.3333e-06 |
| Coke Oven Emissions | 1.6129e-04 |
| Nickel Compounds | 3.8462e-04 |
| Polycylic Organic Matter | |
| 56553 | Benz(a)anthracene | 5.8824e-05 |
| 205992 | Benzo(b)fluoranthene | 5.8824e-05 |
| 207089 | Benzo(k)fluoranthene | 5.8824e-05 |
| 50328 | Benzo(a)pyrene | 5.8824e-05 |
| 53703 | Dibenz(a,h)anthracene | 5.8824e-05 |
| 193395 | Indeno(1,2,3-cd)pyrene | 5.8824e-05 |
TABLE 2
| CAS # | CHEMICAL | NONCANCER CHRONIC ANNUAL (µg/m3) | NONCANCER ACUTE ANNUAL (µg/m3) |
| 75070 | Acetaldehyde | 9.0000e-02 | |
| 107028 | Acrolein | 2.2000e-04 | 2.5000e-02 |
| 79061 | Acrylamide | 7.0000e-03 | |
| 79107 | Acrylic Acid | 1.0000e-02 | |
| 107131 | Acrylonitrile | 2.0000e-02 | |
| 107051 | Allyl Chloride | 1.0000e-02 | |
| 62533 | Aniline | 1.0000e-02 | |
| 71432 | Benzene | 7.1000e-01 | |
| 92875 | Benzidine | 1.0000e-01 | |
| 100447 | Benzyl Chloride | 1.2000e-01 | 5.0000e-01 |
| 117817 | Bis(2-Ethylhexyl) Phthalate | 7.0000e-01 | |
| (DEHP) | | |
| 75150 | Carbon Disulfide | 7.0000e+00 | |
| 56235 | Carbon Tetrachloride | 2.4000e-02 | 1.9000e+00 |
| 7782505 | Chlorine | 7.1000e-01 | 2.3000e-01 |
| 532274 | 2-Chloroacetophenone | 3.0000e-04 | |
| 108907 | Chlorobenzene | 7.0000e-01 | |
| 67663 | Chloroform | 3.5000e-01 | |
| 126998 | Chloroprene | 1.0000e-02 | |
| 1319773 | Cresols/Cresylic Acid | 1.8000e+00 | |
| 95487 | o-Cresol | 1.8000e+00 | |
| 108394 | m-Cresol | 1.8000e+00 | |
| 106445 | p-Cresol | 1.8000e+00 | |
| 132649 | Dibenzofurans | 3.5000e-08 | |
| 96128 | 1,2-Dibromo-3-Chloropropane | 2.0000e-03 | |
| 106467 | 1,4-Dichlorobenzene (p) | 8.0000e+00 | |
| 542756 | 1,3-Dichloropropene | 2.0000e-01 | |
| 62737 | Dichlorvos | 5.0000e-03 | |
| 68122 | Dimethyl Formamide | 3.0000e-01 | |
| 123911 | 1,4-Dioxane (1,4-Diethyleneoxide) | 4.0000e-02 | 2.0000e+01 |
| 106898 | Epichlorohydrin | 1.0000e-02 | |
| 106887 | 1,2-Epoxybutane | 2.0000e-01 | |
| 140885 | Ethyl Acrylate | 4.8000e-01 | |
| 100414 | Ethyl Benzene | 1.0000e+01 | |
| 75003 | Ethyl Chloride (Chloroethane) | 1.0000e+02 | |
| 106934 | Ethylene Dibromide | 4.6000e-02 | |
| 107062 | Ethylene Dichloride | 9.5000e-01 | |
| 75218 | Ethylene Oxide | 6.0000e+00 | |
| 50000 | Formaldehyde | 3.6000e-02 | 3.7000e+00 |
| 118741 | Hexachlorobenzene | 2.8000e-02 | |
| 77474 | Hexachlorocyclopentadiene | 2.4000e-03 | |
| 822060 | Hexamethylene-1,6-Diisocyanate | 1.0000e-04 | |
| 110543 | Hexane | 2.0000e+00 | |
| 302012 | Hydrazine | 2.4000e-03 | |
| 7647010 | Hydrochloric Acid | 2.0000e-01 | 3.0000e+01 |
| 7664393 | Hydrogen Fluoride (HF Acid) | 5.9000e-02 | 5.8000e+00 |
| 58899 | Lindane (All Isomers) | 1.0000e-02 | |
| 108316 | Maleic Anhydride | 2.4000e-02 | 1.0000e-01 |
| 67561 | Methanol | 6.2000e+00 | |
| 74839 | Methyl Bromide | 5.0000e-02 | |
| (Bromomethane) | | |
| 71556 | Methyl Chloroform | 3.2000e+00 | 1.9000e+03 |
| 78933 | Methyl Ethyl Ketone | 1.0000e+01 | |
| (2-Butanone) | | |
| 624839 | Methyl Isocyanate | 3.6000e-03 | |
| 80626 | Methyl Methacrylate | 9.8000e+00 | |
| 1634044 | Methyl Tert Butyl Ether | 3.0000e+01 | |
| 75092 | Methylene Chloride | 3.0000e+01 | 3.5000e+01 |
| 101688 | Methylene Diphenyl | 2.0000e-04 | |
| Diisocyanate | | |
| 101779 | 4,4'-Methylenedianiline | 1.9000e-02 | |
| 91203 | Naphthalene | 1.4000e-01 | |
| 98953 | Nitrobenzene | 1.7000e-02 | |
| 79469 | 2-Nitropropane | 2.0000e-01 | |
| 87865 | Pentachlorophenol | 2.0000e-03 | |
| 108952 | Phenol | 4.5000e-01 | |
| 75445 | Phosgene | 1.2000e+00 | |
| 7803512 | Phosphine | 3.0000e-03 | |
| 7723140 | Phosphorus | 7.0000e-04 | |
| 85449 | Phthalic Anhydride | 7.0000e+01 | |
| 1336363 | Polychlorinated Biphenyls | 1.2000e-02 | |
| 78875 | Propylene Dichloride | 4.0000e-02 | |
| 75569 | Propylene Oxide | 3.0000e-01 | 1.0000e+01 |
| 100425 | Styrene | 1.0000e+01 | |
| 1746016 | 2,3,7,8-TCDD | 3.5000e-08 | |
| 127184 | Tetrachloroethylene (Perch) | 3.5000e-01 | 6.8000e+01 |
| 108883 | Toluene | 4.0000e+00 | |
| 584849 | 2,4-Toluene Diisocyanate | 7.0000e-04 | |
| 79016 | Trichloroethylene | 6.4000e+00 | |
| 121448 | Triethylamine | 7.0000e-02 | |
| 108054 | Vinyl Acetate | 2.0000e+00 | |
| 593602 | Vinyl Bromide | 3.0000e-02 | |
| 75014 | Vinyl Chloride | 2.6000e-01 | |
| 75354 | Vinylidene Chloride | 3.2000e-01 | |
| 1330207 | Xylenes (Isomers and Mixture) | 3.0000e+00 | 4.4000e+01 |
| Antimony Compounds | 2.0000e-03 | |
| Arsenic Compounds | 5.0000e-03 | |
| Beryllium Compounds | 4.8000e-05 | |
| Cadmium Compounds | 3.5000e-02 | |
| Chromium Compounds | 2.0000e-05 | |
| Cyanide Compounds | 7.0000e-01 | 3.3000e+01 |
| Ethyl Glycol | 2.0000e-01 | |
| But Ether | | |
| Ethyl Glycol | 3.7000e+00 | |
| Ethyl Ether | | |
| Ethyl Gly MonoBut | 1.5000e+01 | |
| Ether | | |
| Ethyl Gly Mono- | 2.0000e+00 | |
| Ethyl Ether | | |
| Ethyl Gly Ethyl | 6.4000e-01 | |
| Ether Acetate | | |
| Ethyl Glycol | 2.0000e-01 | 3.2000e+00 |
| Methyl Ether | | |
| Ethyl Gly Methyl | 5.7000e-01 | |
| Ether Acetate | | |
| Ethyl Gly Mono- | 1.6000e+01 | |
| Ethyl Ether Acetate | | |
| Lead Compounds | 1.5000e-02 | |
| Manganese Compounds | 5.0000e-04 | |
| Mercury Compounds | 3.0000e-03 | 3.0000e-01 |
| Fine Mineral | 2.4000e-01 | |
| Fibers | | |
| Nickel Compounds | 2.4000e-03 | 1.0000e-02 |
| Selenium Compounds | 5.0000e-03 | 2.0000e-02 |
NEW, 2002 MAR p. 3567, Eff. 12/27/02.75-2-111, 75-2-204, MCA; IMP, 75-2-204, 75-2-211, 75-2-215, MCA;